• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ST. JUDE MEDICAL, INC.(CRM-SYLMAR) FORTIFY VR, U1.6 SJ4 US; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ST. JUDE MEDICAL, INC.(CRM-SYLMAR) FORTIFY VR, U1.6 SJ4 US; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR Back to Search Results
Model Number CD1231-40Q
Device Problems Premature Discharge of Battery (1057); Failure to Interrogate (1332)
Patient Problems Death (1802); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 12/14/2020
Event Type  Death  
Manufacturer Narrative
The results of the investigation are inconclusive since the device was not returned for analysis.Based on the information received, the cause of the reported incident could not be conclusively determined.
 
Event Description
It was reported that a patient presented with an implantable cardioverter defibrillator could not be interrogated.Multiple programmers and wands were used in different locations and distances to no avail.A couple days later, the patient expired.It was unknown if the telemetry issue or any other issue involving the device or implanted lead was responsible for the patient's death.Related manufacturer reference number: 2017865-2021-00018.
 
Manufacturer Narrative
Communication failure and premature battery depletion were confirmed by analysis.A device evaluation was performed, and no sources of high current were noted.The cause of the premature battery depletion was consistent with li cluster formation.From these analyses, in the absence of high current draw, it is probable that the premature battery depletion was caused by a lithium cluster induced short circuit.Li clusters are a known depletion mechanism for these advisory products that has been investigated and associated with a field action in october 2016.
 
Manufacturer Narrative
Communication failure and premature battery depletion were confirmed by analysis.A longevity calculation was performed based upon programmed settings and usage data up to end of service (eos) timestamp.The calculations showed the battery depleted prematurely.The cause of premature battery depletion could not be conclusively determined.
 
Event Description
New information notes that patient's history of ventricular tachycardia storms that were addressed with therapies could have contributed to rapid battery depletion that led to loss of telemetry.
 
Manufacturer Narrative
The reported field event of communication failure was confirmed by analysis.The cause of communication failure was due to low battery voltage.A longevity calculation was performed based upon programmed settings and usage data up to end of service (eos) timestamp.The calculations showed the device did not meet its overall expected longevity requirements.In an effort to isolate the root-cause, extensive bench testing was performed; in the lab and by the battery manufacturer.The battery analysis by the manufacturer indicated three clusters were found in the cell.None of the clusters were in a location that could have resulted in premature battery depletion.No sources of high current drain on the hybrid were noted.Device¿s functionality was tested; pacing, sensing, impedance, high voltage output, and patient notifier were tested and no anomaly was detected.No component anomalies or malfunctions that would account for premature battery depletion were identified in the device.As per the follow-up communication with the field, it was indicated that the patient had a history of multiple ventricular tachycardia (vt) events and high voltage therapies.It is quite possible that the patient had on-going arrhythmia and received appropriate therapies during october (b)(6) 2020, which would then have exhausted the battery normally.However, since the device image and/sessions during this timeframe were not available, the cause of the rapid battery depletion could not be conclusively determined.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FORTIFY VR, U1.6 SJ4 US
Type of Device
IMPLANTABLE CARDIOVERTER DEFIBRILLATOR
Manufacturer (Section D)
ST. JUDE MEDICAL, INC.(CRM-SYLMAR)
15900 valley view court
sylmar CA 91342
MDR Report Key11105650
MDR Text Key224732055
Report Number2017865-2021-00017
Device Sequence Number1
Product Code NVZ
UDI-Device Identifier05414734504348
UDI-Public05414734504348
Combination Product (y/n)N
PMA/PMN Number
P910023
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Remedial Action Recall
Type of Report Initial,Followup,Followup,Followup
Report Date 07/13/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date02/28/2013
Device Model NumberCD1231-40Q
Device Catalogue NumberCD1231-40Q
Device Lot Number3472889
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer12/30/2020
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 12/14/2020
Initial Date FDA Received01/03/2021
Supplement Dates Manufacturer Received03/01/2021
05/18/2021
07/09/2021
Supplement Dates FDA Received03/21/2021
06/11/2021
07/13/2021
Is This a Reprocessed and Reused Single-Use Device? No
Removal/Correction NumberZ-0115-2017
Patient Sequence Number1
Treatment
DURATA STS OPTIM ACTIVE FIXATION, DF-4 CONNECTOR
Patient Outcome(s) Death;
Patient Age74 YR
Patient Weight107
-
-